|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Salix_Pharmaceuticals
gptkb:Bausch_+_Lomb
gptkb:Ortho_Dermatologics
|
|
gptkbp:advertising
|
gptkb:Mr._David_A._Johnson
gptkb:Dr._Jennifer_L._Smith
Mr. Robert C. White
Mr. Steven R. Adams
Ms. Laura K. Thompson
|
|
gptkbp:ceo
|
gptkb:Joseph_C._Papa
|
|
gptkbp:conducts_research_on
|
gptkb:Dr._Thomas_J._O'_Brien
|
|
gptkbp:focus
|
Gastroenterology
Dermatology
Eye health
|
|
gptkbp:founded
|
gptkb:2013
|
|
gptkbp:founder
|
gptkb:Bausch_&_Lomb
|
|
gptkbp:global_presence
|
gptkb:Yes
|
|
gptkbp:has_authority_over
|
Ms. Karen L. White
Ms. Sarah K. Green
|
|
gptkbp:head
|
Ms. Angela R. Davis
|
|
gptkbp:head_of_global_corporate_affairs
|
Ms. Jennifer L. Brown
|
|
gptkbp:head_of_global_hr
|
Mr. Charles M. King
|
|
gptkbp:head_of_global_it
|
Ms. Michelle A. Scott
|
|
gptkbp:head_of_state
|
Ms. Patricia A. Martinez
Mr. Michael T. Lee
Ms. Linda M. Brown
|
|
gptkbp:headquarters
|
gptkb:Laval,_Quebec,_Canada
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bausch Health Companies
|
|
gptkbp:industry
|
Healthcare
|
|
gptkbp:investment
|
Mr. Daniel J. Harris
Mr. David T. Wilson
Mr. Richard T. Young
|
|
gptkbp:market_cap
|
~$8 billion (2021)
|
|
gptkbp:number_of_employees
|
~21,000
|
|
gptkbp:partnership
|
Various healthcare organizations
|
|
gptkbp:philanthropy
|
Bausch Foundation
|
|
gptkbp:products
|
Medical devices
Prescription drugs
Over-the-counter products
|
|
gptkbp:regulatory_compliance
|
FDA approved products
Mr. Thomas R. Green
Mr. James P. Wilson
|
|
gptkbp:research_focus
|
Innovative therapies
|
|
gptkbp:revenue
|
$8.1 billion (2020)
|
|
gptkbp:stock_symbol
|
BHC
|
|
gptkbp:strategy
|
Ms. Emily R. Clark
|
|
gptkbp:subsidiary
|
gptkb:Salix_Pharmaceuticals
gptkb:Bausch_+_Lomb
gptkb:Ortho_Dermatologics
|
|
gptkbp:sustainability_initiatives
|
Environmental responsibility
|
|
gptkbp:traded_on
|
gptkb:NYSE
|
|
gptkbp:type
|
gptkb:pharmaceuticals
|
|
gptkbp:website
|
www.bauschhealth.com
|
|
gptkbp:bfsParent
|
gptkb:Bausch_&_Lomb
|
|
gptkbp:bfsLayer
|
5
|